pH-dependent binding modes observed in trypsin crystals: lessons for structure-based drug design

pH-dependent binding modes observed in trypsin crystals: lessons for structure-based drug design

Item
http://www.wikidata.org/entity/Q27638635
Fragment deconstruction of small, potent factor Xa inhibitors: exploring the superadditivity energetics of fragment linking in protein-ligand complexesN-terminal protein modification by substrate-activated reverse proteolysisPerspective: Alchemical free energy calculations for drug discovery.Ligand scaffold hopping combining 3D maximal substructure search and molecular similarity.The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A.Detection and characterization of nonspecific, sparsely populated binding modes in the early stages of complexation.Binding of small-molecule ligands to proteins: "what you see" is not always "what you get".Oral, direct thrombin and factor Xa inhibitors: the replacement for warfarin, leeches, and pig intestines?The application of bioisosteres in drug design for novel drug discovery: focusing on acid protease inhibitors.Empirical Scoring Functions for Affinity Prediction of Protein-ligand Complexes.Cl-pi interactions in protein-ligand complexes.Trypsin mutants for structure-based drug design: expression, refolding and crystallisation.Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators.Discovery of new antifungal leads via pharmacophore modeling and QSAR analysis of fungal N-myristoyl transferase inhibitors followed by in silico screening.
P2860

pH-dependent binding modes observed in trypsin crystals: lessons for structure-based drug design

Item
http://www.wikidata.org/entity/Q27638635
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
pH-dependent binding modes obs ...... or structure-based drug design
@ast
pH-dependent binding modes obs ...... or structure-based drug design
@en
pH-dependent binding modes obs ...... or structure-based drug design
@nl
type
label
pH-dependent binding modes obs ...... or structure-based drug design
@ast
pH-dependent binding modes obs ...... or structure-based drug design
@en
pH-dependent binding modes obs ...... or structure-based drug design
@nl
prefLabel
pH-dependent binding modes obs ...... or structure-based drug design
@ast
pH-dependent binding modes obs ...... or structure-based drug design
@en
pH-dependent binding modes obs ...... or structure-based drug design
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
pH-dependent binding modes obs ...... or structure-based drug design
@en
P2093
P304
P31
P356
10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO;2-#
P433
P478
P50
P577
P698